Literature DB >> 34167645

Multi-Ethnic Study of Atherosclerosis (MESA): JACC Focus Seminar 5/8.

Michael J Blaha1, Andrew P DeFilippis2.   

Abstract

The MESA (Multi-Ethnic Study of Atherosclerosis) is a National Heart, Lung, and Blood Institute-sponsored prospective study aimed at studying the prevalence, progression, determinants, and prognostic significance of subclinical cardiovascular disease in a sex-balanced, multiethnic, community-dwelling U.S. cohort. MESA helped usher in an era of noninvasive evaluation of subclinical atherosclerosis presence, burden, and progression for the evaluation of atherosclerotic cardiovascular disease risk, beyond what could be predicted by traditional risk factors alone. Concepts developed in MESA have informed international patient care guidelines, providing new tools to effectively guide public health policy, population screening, and clinical decision-making. MESA is grounded in an open science model that continues to be a beacon for collaborative science. In this review, we detail the original goals of MESA, and describe how the scope of MESA has evolved over time. We highlight 10 significant MESA contributions to cardiovascular medicine, and chart the path forward for MESA in the year 2021 and beyond.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis; epidemiology; risk prediction; subclinical disease

Mesh:

Substances:

Year:  2021        PMID: 34167645      PMCID: PMC8091185          DOI: 10.1016/j.jacc.2021.05.006

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  4 in total

1.  Response by Peng et al to Letter Regarding Article, "Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".

Authors:  Allison W Peng; Zeina A Dardari; Michael J Blaha
Journal:  Circulation       Date:  2021-10-25       Impact factor: 29.690

2.  Establishing a National Cardiovascular Disease Surveillance System in the United States Using Electronic Health Record Data: Key Strengths and Limitations.

Authors:  Brent A Williams; Stephen Voyce; Stephen Sidney; Véronique L Roger; Timothy B Plante; Sharon Larson; Michael J LaMonte; Darwin R Labarthe; Bailey M DeBarmore; Alexander R Chang; Alanna M Chamberlain; Catherine P Benziger
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

3.  Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.

Authors:  Nathan D Wong; Matthew J Budoff; Keith Ferdinand; Ian M Graham; Erin D Michos; Tina Reddy; Michael D Shapiro; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2022-03-15

Review 4.  Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment.

Authors:  Anastasia V Poznyak; Nikolay K Sadykhov; Andrey G Kartuesov; Evgeny E Borisov; Alexandra A Melnichenko; Andrey V Grechko; Alexander N Orekhov
Journal:  Front Cardiovasc Med       Date:  2022-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.